Literature DB >> 10856973

Endothelial cell function and thrombosis.

J D Pearson1.   

Abstract

The endothelium is pivotal in the control of haemostasis and thrombosis because it is the primary source of many of the major haemostatic regulatory molecules. Healthy endothelial cells, unlike extravascular cells, are anticoagulant and antithrombotic. This is due to the regulated secretion of antiplatelet agents, including prostacyclin and nitric oxide. Following vessel injury, platelet adhesion to exposed matrix requires von Willebrand Factor, another endothelial cell product. Local generation of thrombin causes a series of receptor-mediated endothelial cell functional responses, while the surface of the endothelium is additionally the site for inactivation of thrombin by antithrombin, and its conversion to a coagulation inhibitor by interaction with thrombomodulin. Endothelial cells are also the source of circulating tissue-type plasminogen activator and its inhibitor, and Tissue Factor pathway inhibitor. In disease states, many of these endothelial cell properties are perturbed towards a more procoagulant and prothrombotic phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10856973     DOI: 10.1053/beha.1999.0028

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Haematol


  29 in total

Review 1.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 2.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

3.  Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.

Authors:  Yao-Hsu Yang; Kwan-Ki Hwang; John FitzGerald; Jennifer M Grossman; Mihaela Taylor; Bevra H Hahn; Pojen P Chen
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  The thrombogenicity of human umbilical vein endothelial cell seeded collagen modules.

Authors:  Alison P McGuigan; Michael V Sefton
Journal:  Biomaterials       Date:  2008-03-05       Impact factor: 12.479

5.  Age-related changes in aortic valve hemostatic protein regulation.

Authors:  Liezl R Balaoing; Allison D Post; Huiwen Liu; Kyung Taeck Minn; K Jane Grande-Allen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-31       Impact factor: 8.311

Review 6.  Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling.

Authors:  Pratish Thakore; Scott Earley
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 7.  Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts.

Authors:  Anthony J Melchiorri; Narutoshi Hibino; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2013-02-13       Impact factor: 6.389

Review 8.  Biomaterials for vascular tissue engineering.

Authors:  Swathi Ravi; Elliot L Chaikof
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

Review 9.  Antibodies to serine proteases in the antiphospholipid syndrome.

Authors:  Pojen P Chen; Ian Giles
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

10.  A Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and Treatments.

Authors:  Ann R Kennedy; Amit Maity; Jenine K Sanzari
Journal:  Radiat Res       Date:  2016-07-26       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.